A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care
Background: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be ver...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2016-10-01
|
Series: | Health Services and Delivery Research |
Online Access: | https://doi.org/10.3310/hsdr04320 |
id |
doaj-52bb92faeab9435185bd2c1cdfd072fe |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Holly Standing Catherine Exley Darren Flynn Julian Hughes Kerry Joyce Trudie Lobban Stephen Lord Daniel Matlock Janet M McComb Paul Paes Richard G Thomson |
spellingShingle |
Holly Standing Catherine Exley Darren Flynn Julian Hughes Kerry Joyce Trudie Lobban Stephen Lord Daniel Matlock Janet M McComb Paul Paes Richard G Thomson A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care Health Services and Delivery Research |
author_facet |
Holly Standing Catherine Exley Darren Flynn Julian Hughes Kerry Joyce Trudie Lobban Stephen Lord Daniel Matlock Janet M McComb Paul Paes Richard G Thomson |
author_sort |
Holly Standing |
title |
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
title_short |
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
title_full |
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
title_fullStr |
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
title_full_unstemmed |
A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
title_sort |
qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care |
publisher |
NIHR Journals Library |
series |
Health Services and Delivery Research |
issn |
2050-4349 2050-4357 |
publishDate |
2016-10-01 |
description |
Background: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be very sophisticated and can provide so-called cardiac resynchronisation therapy for the treatment of heart failure using a pacemaker (cardiac resynchronisation therapy with pacemaker) or combined with an ICD [cardiac resynchronisation therapy with defibrillator (CRT-D)]. Decision-making about these devices involves considering the benefit (averting sudden cardiac death), possible risks (inappropriate shocks and psychological problems) and the potential need for deactivation towards the end of life. Objectives: To explore patients’/relatives’ and clinicians’ views/experiences of decision-making about ICD and CRT-D implantation and deactivation, to establish how and when ICD risks, benefits and consequences are communicated to patients, to identify individual and organisational facilitators and barriers to discussions about implantation and deactivation and to determine information and decision-support needs for shared decision-making (SDM). Data sources: Observations of clinical encounters, in-depth interviews and interactive group workshops with clinicians, patients and their relatives. Methods: Observations of consultations with patients being considered for ICD or CRT-D implantation were undertaken to become familiar with the clinical environment and to optimise the sampling strategy. In-depth interviews were conducted with patients, relatives and clinicians to gain detailed insights into their views and experiences. Data collection and analysis occurred concurrently. Interactive workshops with clinicians and patients/relatives were used to validate our findings and to explore how these could be used to support better SDM. Results: We conducted 38 observations of clinical encounters, 80 interviews (44 patients/relatives, seven bereaved relatives and 29 clinicians) and two workshops with 11 clinicians and 11 patients/relatives. Patients had variable knowledge about their conditions, the risk of sudden cardiac death and the clinical rationale for ICDs, which sometimes resulted in confusion about the potential benefits. Clinicians used various metaphors, verbal descriptors and numerical risk methods, including variable disclosure of the potential negative impact of ICDs on body image and the risk of psychological problems, to convey information to patients/relatives. Patients/relatives wanted more information about, and more involvement in, deactivation decisions, and expressed a preference that these decisions be addressed at the time of implantation. There was no consensus among clinicians about the initiation or timing of such discussions, or who should take responsibility for them. Introducing deactivation discussions prior to implantation was thus contentious; however, trigger points for deactivation discussions embedded within the pathway were suggested to ensure timely discussions. Limitations: Only two patients who were prospectively considering deactivation and seven bereaved relatives were recruited. The study also lacks the perspectives of primary care clinicians. Conclusions: There is discordance between patients and clinicians on information requirements, in particular the potential consequences of implantation on psychological well-being and quality of life in the short and long term (deactivation). There were no agreed points across the care pathway at which to discuss deactivation. Codesigned information tools that present balanced information on the benefits, risks and consequences, and SDM skills training for patients/relative and clinicians, would support better SDM about ICDs. Future work: Multifaceted SDM interventions that focus on skills development for SDM combined with decision-support tools are warranted, and there is a potential central role for heart failure nurses and physiologists in supporting and preparing patients/relatives for such discussions. Funding: The National Institute for Health Research Health Services and Delivery Research programme. |
url |
https://doi.org/10.3310/hsdr04320 |
work_keys_str_mv |
AT hollystanding aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT catherineexley aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT darrenflynn aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT julianhughes aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT kerryjoyce aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT trudielobban aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT stephenlord aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT danielmatlock aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT janetmmccomb aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT paulpaes aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT richardgthomson aqualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT hollystanding qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT catherineexley qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT darrenflynn qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT julianhughes qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT kerryjoyce qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT trudielobban qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT stephenlord qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT danielmatlock qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT janetmmccomb qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT paulpaes qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare AT richardgthomson qualitativestudyofdecisionmakingabouttheimplantationofcardioverterdefibrillatorsanddeactivationduringendoflifecare |
_version_ |
1716809033969565696 |
spelling |
doaj-52bb92faeab9435185bd2c1cdfd072fe2020-11-24T20:48:03ZengNIHR Journals LibraryHealth Services and Delivery Research2050-43492050-43572016-10-0143210.3310/hsdr0432011/2004/29A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life careHolly Standing0Catherine Exley1Darren Flynn2Julian Hughes3Kerry Joyce4Trudie Lobban5Stephen Lord6Daniel Matlock7Janet M McComb8Paul Paes9Richard G Thomson10Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKPolicy, Ethics and Life Sciences Research Centre, Newcastle University, Newcastle upon Tyne, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKArrhythmia Alliance: The Heart Rhythm Charity, Stratford-upon-Avon, UKNewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USANewcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKNorthumbria Healthcare NHS Foundation Trust, North Shields, UKInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UKBackground: Implantable cardioverter defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death or for survivors of cardiac arrest. All ICDs combine a shock function with a pacing function to treat fast and slow heart rhythms, respectively. The pacing function may be very sophisticated and can provide so-called cardiac resynchronisation therapy for the treatment of heart failure using a pacemaker (cardiac resynchronisation therapy with pacemaker) or combined with an ICD [cardiac resynchronisation therapy with defibrillator (CRT-D)]. Decision-making about these devices involves considering the benefit (averting sudden cardiac death), possible risks (inappropriate shocks and psychological problems) and the potential need for deactivation towards the end of life. Objectives: To explore patients’/relatives’ and clinicians’ views/experiences of decision-making about ICD and CRT-D implantation and deactivation, to establish how and when ICD risks, benefits and consequences are communicated to patients, to identify individual and organisational facilitators and barriers to discussions about implantation and deactivation and to determine information and decision-support needs for shared decision-making (SDM). Data sources: Observations of clinical encounters, in-depth interviews and interactive group workshops with clinicians, patients and their relatives. Methods: Observations of consultations with patients being considered for ICD or CRT-D implantation were undertaken to become familiar with the clinical environment and to optimise the sampling strategy. In-depth interviews were conducted with patients, relatives and clinicians to gain detailed insights into their views and experiences. Data collection and analysis occurred concurrently. Interactive workshops with clinicians and patients/relatives were used to validate our findings and to explore how these could be used to support better SDM. Results: We conducted 38 observations of clinical encounters, 80 interviews (44 patients/relatives, seven bereaved relatives and 29 clinicians) and two workshops with 11 clinicians and 11 patients/relatives. Patients had variable knowledge about their conditions, the risk of sudden cardiac death and the clinical rationale for ICDs, which sometimes resulted in confusion about the potential benefits. Clinicians used various metaphors, verbal descriptors and numerical risk methods, including variable disclosure of the potential negative impact of ICDs on body image and the risk of psychological problems, to convey information to patients/relatives. Patients/relatives wanted more information about, and more involvement in, deactivation decisions, and expressed a preference that these decisions be addressed at the time of implantation. There was no consensus among clinicians about the initiation or timing of such discussions, or who should take responsibility for them. Introducing deactivation discussions prior to implantation was thus contentious; however, trigger points for deactivation discussions embedded within the pathway were suggested to ensure timely discussions. Limitations: Only two patients who were prospectively considering deactivation and seven bereaved relatives were recruited. The study also lacks the perspectives of primary care clinicians. Conclusions: There is discordance between patients and clinicians on information requirements, in particular the potential consequences of implantation on psychological well-being and quality of life in the short and long term (deactivation). There were no agreed points across the care pathway at which to discuss deactivation. Codesigned information tools that present balanced information on the benefits, risks and consequences, and SDM skills training for patients/relative and clinicians, would support better SDM about ICDs. Future work: Multifaceted SDM interventions that focus on skills development for SDM combined with decision-support tools are warranted, and there is a potential central role for heart failure nurses and physiologists in supporting and preparing patients/relatives for such discussions. Funding: The National Institute for Health Research Health Services and Delivery Research programme.https://doi.org/10.3310/hsdr04320 |